Freudenberg Medical has made a $25 million investment to establish a second manufacturing site in Costa Rica. The expansion will allow the company to increase its technologies and deliver more products to its global customer base. 
 
“We are proud to be one of the first global CDMO partners in Costa Rica, having established our first production facility here more than 12 years ago,” said Dr. Mark Ostwald, CEO of Freudenberg Medical. “This expansion strengthens our strategy of being close to our customers and offering them efficient solutions along the entire device lifecycle – including cost-effective manufacturing capabilities on a large scale.”
 
The new site will be operational at the beginning of 2025. The facility will be dedicated to assembling structural heart therapies, minimally invasive catheters for electrophysiology, and other medical devices that require high-precision manual assembly. 
 
The first phase of the new facility will cover 50,000 square feet, housing three ISO 7 cleanrooms. Within three years of opening, Freudenberg Medical will add 50,000 square feet, quadrupling its Costa Rica footprint. 
 
The new facility will be located near Freudenberg Medical’s existing manufacturing facility in the Coyol Free Zone. In 2025 the Coyol Free Zone facility will be primarily used for processing technologies including molding and extrusion of thermoplastics. 
 
“The investment in this new site underlines Freudenberg Medical’s confidence in Costa Rica as an integral part of our global growth strategy,” said Róger Gómez, VP/General Manager of Freudenberg Medical in Costa Rica. “In the next three years we will triple the number of employees from the current 300 to over 900 team members. Committed to diversity and inclusion, we offer equal opportunities to all.” 
 
The new facility will be dedicated to assembly and operations and built to the highest environmental and energy efficiency standards. A company-owned PV solar power plant will generate the energy to operate the site. The two-story building will also be barrier-free to meet the needs of people with impairments.
 
“This is another important step towards our goal of becoming a climate-neutral company by 2045,” said Dr. Tilman Krauch, CTO of the Freudenberg Group. “Since the beginning of our company 175 years ago, we have taken responsibility for the communities in which we are at home, as well as for our environment and a sustainable future.”